<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-vaccines-08-00043">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bommakanti</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Citron</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Hepler</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Callahan</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Heidecker</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Najar</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Joyce</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Shiver</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Casimiro</surname>
    <given-names>D.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2010</year>
  <volume>107</volume>
  <fpage>13701</fpage>
  <lpage>13706</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1007465107</pub-id>
  <pub-id pub-id-type="pmid">20615991</pub-id>
 </element-citation>
</ref>
